Stay updated on HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page.

Latest updates to the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record now presents details of the HMPL-306 Phase 1 study, including its treatment plan, eligibility criteria, outcome measures, and a recruiting location in Beijing. It also includes study history and a related publication.SummaryDifference48%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the study record remains inaccessible with a 403 Forbidden message.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide banner announces NIH website updates and FAQs, including a notice about using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe Study Record page now shows a 403 Forbidden error instead of the study details, indicating an access restriction. This prevents users from viewing the record and its related information.SummaryDifference18%

Stay in the know with updates to HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page.